Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding

A Delaware jury ruled in favor of Cytek Biosciences on three of four asserted patent claims, finding noninfringement and invalidity on those claims in a case brought by Beckman Coulter. However, the jury found infringement under the doctrine of equivalents on the remaining claim and awarded total damages of $56 million, consisting of $20 million in lost profits and $36 million in royalties.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.